MedTrace Logo

Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine

NCT01603940 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-02-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare losartan and benazepril in diabetic patients whose high blood pressure is not controlled by amlodipine and its relationship to statin current use.

Conditions

Interventions

DRUG

Benazepril

Patients in this group will receive 20 mg of benazepril per day, orally, during 12 weeks.

DRUG

Losartan

Patients in this group will receive 100 mg of losartan per day, orally, during 12 weeks.

Sponsors & Collaborators

  • Hospital Universitario Pedro Ernesto

    lead OTHER

Principal Investigators

  • Wille Oigman, MD, DSc. · Hospital Universitario Pedro Ernesto

  • Mario F Neves, MD, DSc. · Hospital Universitario Pedro Ernesto

  • Ronaldo A Gismondi, MD, MSc. · Hospital Universitario Pedro Ernesto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01603940 on ClinicalTrials.gov